Literature DB >> 1720309

Distribution of plural HCV types in Japan.

N Kato1, Y Ootsuyama, S Ohkoshi, T Nakazawa, S Mori, M Hijikata, K Shimotohno.   

Abstract

A detection system was developed to distinguish the four different HCV genomes [HCV-J, HCV-US, HCV-K2 and group II HCV (HCV-GII)], involving reverse transcription followed by a nested polymerase chain reaction using specific primers for each HCV type. The putative non-structural (NS) 5 regions of HCV-J, HCV-US and HCV-K2 and the putative NS3 region of HCV-GII were amplified. Of 95 specimens from patients with acute hepatitis, chronic hepatitis, liver cirrhosis or hepatocellular carcinoma, 67 specimens were positive for HCV-J, 2 for HCV-US, 23 for HCV-K2 and 11 for HCV-GII. About half the specimens that were positive for HCV-K2 or HCV-GII were coinfected with HCV-J and all those that were positive for HCV-GII were also positive for HCV-K2. Nucleotide sequence analysis of several amplified cDNA products revealed that HCV-K2 and HCV-GII could each be classified into two groups, and the pattern of classification of HCV-K2 was identical with that of HCV-GII. Therefore, our results strongly suggest that HCV-K2 is the same as HCV-GII.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720309     DOI: 10.1016/s0006-291x(05)81414-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Recent advances in hepatitis C virus research.

Authors:  M Omata; N Kato
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

2.  Prevalence of HCV genotype among patients with chronic liver diseases in the Tokyo metropolitan area.

Authors:  M Kobayashi; H Kumada; K Chayama; Y Arase; S Saitou; A Tsubota; I Koida; K Ikeda; M Hashimoto; S Iwasaki
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

Review 3.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier.

Authors:  S Ohkoshi; H Tawaraya; K Kuwana; T Harada; M Watanabe; S Higuchi; H Kojima; T Kamimura; H Asakura
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand.

Authors:  C Apichartpiyakul; C Chittivudikarn; H Miyajima; M Homma; H Hotta
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.

Authors:  N Kato; Y Ootsuyama; H Sekiya; S Ohkoshi; T Nakazawa; M Hijikata; K Shimotohno
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C.

Authors:  S K Yoon; S S Kim; Y M Park; K S Shim; C D Lee; H S Sun; D H Park; B S Kim; W S Ryu; J M Cho
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

10.  Molecular typing of hepatitis C virus genome from sera and liver tissues of patients with anti-HCV positive chronic liver disease.

Authors:  S K Yoon; Y M Park; K W Chung; B S Kim; C J Kim; W Y Kim; S K Chang; M J Cho
Journal:  Korean J Intern Med       Date:  1993-07       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.